Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-20

Clinical Trial Update: Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in Tanzania [Phase 4]

View source ↗

Summary

This Phase 4 trial update evaluates the implementation and effectiveness of intermittent preventive treatment for malaria in school-aged children in Tanzania us…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)

Snippet

Sponsor: National Institute for Medical Research, Tanzania | Conditions: Malaria | Phase 4 | Status: COMPLETED